Table 6.
Adverse events or acute health complications reported throughout the study.
| Adverse events, N (%): | Placebo (n = 19) | Intervention (n = 21) | p-value |
|---|---|---|---|
| Bronchitis/cough/respiratory infection | 2 (8) | 4 (19) | 0.45 |
| Cold symptoms | 7 (29) | 9 (43) | 0.70 |
| Constipation | 3 (13) | 1 (5) | 0.25 |
| Diarrhea | 1 (4) | 4 (19) | 0.19 |
| Emesis/nausea | 4 (21) | 7 (33) | 0.39 |
| Fever | 2 (8) | 4 (19) | 0.45 |
| Rash | 0 (0) | 1 (5) | 0.34 |
| Other/etc. | 3 (13) | 4 (19) | 0.77 |